MIFH
Migdal Insurance & Financial Holdings Portfolio holdings
AUM
$11.6B
1-Year Est. Return
32.37%
This Fund
S&P 500
1 Year Est. Return
+32.37%
AUM
$9.29B
AUM Growth
+$864M
(+10%)
Holding
401
Top Buys
| 1 | +$195M | |
| 2 | +$138M | |
| 3 | +$90.4M | |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$68.4M |
| 5 |
Broadcom
AVGO
|
+$56.3M |
Top Sells
| 1 | +$182M | |
| 2 | +$143M | |
| 3 | +$64.9M | |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$62.2M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$61.3M |
Sector Composition
| 1 | Technology | 28.44% |
| 2 | Healthcare | 10.21% |
| 3 | Communication Services | 6.77% |
| 4 | Consumer Discretionary | 5.98% |
| 5 | Financials | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
401
State Street SPDR S&P Biotech ETF
XBI
$7.73B
| – | – |
-750,000
|
|